Controling Intestinal Colonization With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae ESBL-E
Status:
Terminated
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
Rapid and rational health-care interventions are of great importance to efficiently combat
the emergence of resistant and virulent bacteria. In recent years, spread of ESBL-E on a
global level has been observed.
For ESBL-E, effective eradication regimens are not yet available. The current study therefore
aims to assess a new approach to ESBL-E eradication. To avoid administration of the
eradication regimen to patients at low risk of subsequent BSI with ESBL-E, the study
population will be restricted to immunocompromised high-risk patients.